Targeted nano‑delivery reduces fungicide overuse and dramatically boosts control of a disease threatening global banana production, advancing sustainable crop protection.
Banana wilt, driven by Fusarium oxysporum TR4, remains a critical threat to the world’s leading fruit export, with conventional fungicide sprays offering limited site specificity and contributing to environmental load. Over‑application not only raises production costs but also accelerates resistance development, prompting a search for delivery technologies that can concentrate actives where the pathogen resides. Precision agriculture concepts have thus turned to nanotechnology, seeking carriers that can navigate plant vascular systems and release actives on demand.
The newly reported nanocarrier leverages tryptophan’s affinity for plant amino‑acid transporters and a polysuccinimide matrix to encapsulate fludioxonil via hydrogen bonds and π‑π interactions. This dual‑mechanism loading yields a 53.74% encapsulation rate, markedly higher than many polymeric carriers. Once applied, the particles travel through the phloem, accumulating in banana rhizomes—the primary infection niche. Field‑simulated pot trials recorded a fivefold increase in disease suppression, alongside restored metabolic profiles in treated plants, confirming that the carrier not only delivers the fungicide but also mitigates pathogen‑induced physiological stress.
Beyond immediate efficacy, the platform signals a shift toward greener agrochemicals. Its biocompatible components exhibit negligible phytotoxicity, reducing collateral damage to crops and surrounding ecosystems. Scaling this technology could lower total fungicide volumes, easing regulatory burdens and supporting sustainability certifications. Future work will need to address large‑scale manufacturing, long‑term field performance, and integration with existing farm management systems, but the amino‑acid‑based nanocarrier sets a promising precedent for targeted, low‑impact crop protection across diverse horticultural sectors.
Comments
Want to join the conversation?
Loading comments...